• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NXSTAGE MEDICAL, INC. NXSTAGE SYSTEM ONE; NEEDLE, FISTULA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NXSTAGE MEDICAL, INC. NXSTAGE SYSTEM ONE; NEEDLE, FISTULA Back to Search Results
Model Number D9-2005MG
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Hypersensitivity/Allergic reaction (1907)
Event Date 12/12/2022
Event Type  Injury  
Manufacturer Narrative
There is no information to indicate that a malfunction occurred.Allergic or adverse reactions are known risks of hemodialysis.Instructions include allergic reaction as a potential risk associated with dialysis therapy and also include warnings to monitor for potential allergic reactions.Biocompatibility of the device has been established.Crane c, cunard ra, sweiss n, scanlon n, doherty ta, potok oa, anaphylaxis from ethylene oxide¿sterilized dialysis tubing and needles: a case report, american journal of kidney diseases (2023), doi: https://doi.Org/10.1053/j.Ajkd.2022.12.004.
 
Event Description
A report was received on 25 jan 2023 from a medical doctor (md) via a literature review regarding a 78-year-old male patient with end stage renal disease, chronic eosinophilia, and recent (10 days) transition from use of a tunneled dialysis catheter (tdc) to use of an arteriovenous fistula (avf), who became increasingly symptomatic while performing hemodialysis sessions with the dialysis tubing and needles.The patient was admitted to the intensive care unit for monitoring on an unspecified date.Additional analysis of the event by the md and involved medical team presented a differential diagnosis of anaphylaxis attributed to ethylene oxide (eto2) and its use in sterilization of the involved dialysis tubing and needles.Per the md, the patient¿s increased exposure to eto2 following transition to use of his avf activated an underlying sensitivity and the ensuing immune response.Following the diagnosis, the patient was pre-medicated prior to dialysis sessions with varied oral doses of antihistamines and corticosteroids and tolerated hemodialysis therapy using the tdc.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NXSTAGE SYSTEM ONE
Type of Device
NEEDLE, FISTULA
Manufacturer (Section D)
NXSTAGE MEDICAL, INC.
350 merrimack street
lawrence MA 01843
Manufacturer (Section G)
MEDIMEXICO S. DE R. L. DE C. V
av. valle imperial no. 10523
parque industrial valle sur
tijuana 22180
MX   22180
Manufacturer Contact
paula rogalski
nxstage medical, inc.
350 merrimack street
lawrence, MA 01843
9784505276
MDR Report Key16302839
MDR Text Key308825758
Report Number3003464075-2023-00015
Device Sequence Number1
Product Code FIE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K910734
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 02/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberD9-2005MG
Device Catalogue NumberD9-2005MG
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/06/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age78 YR
Patient SexMale
-
-